Reaktion #1556400

ord-94cdf21229864661b3a546640f327478

Reaktionsgleichung

O=C1CCC(=O)N1Cl
N-chlorosuccinimide
CC(C)(C)OC(=O)N1CCC(c2nc(C=NO)cs2)CC1
tert-butyl 4-{4-[(hydroxyimino)methyl]-1,3-thiazol-2-yl}piperidine-1-carboxylate
C=Cc1ccccc1O
2-vinylphenol
O=C([O-])O.[K+]
potassium hydrogencarbonate
CC(C)(C)OC(=O)N1CCC(c2nc(C3=NOC(c4ccccc4O)C3)cs2)CC1
tert-Butyl 4-{4-[5-(2-hydroxyphenyl)-4,5-dihydro-1,2-oxazol-3-yl]-1,3-thiazol-2-yl}piperidine-1-carboxylate

Reaktionsbedingungen

Temperatur
60°CELSIUS
Detaillierte Bedingungen
See reaction.notes.procedure_details.

Aufarbeitung

  1. 1
    Extraktionwas extracted with ethyl acetate
  2. 2
    TrocknenThe organic extracts were dried over sodium sulphate
  3. 3
    Einengenconcentrated under reduced pressure
  4. 4
    SonstigeThe residue was purified by chromatography

Vorschrift

To a solution of tert-butyl 4-{4-[(hydroxyimino)methyl]-1,3-thiazol-2-yl}piperidine-1-carboxylate (3.46 g) and 2-vinylphenol (1.60 g) in ethyl acetate (50 ml) were added, at room temperature, potassium hydrogencarbonate (5.55 g) and N-chlorosuccinimide (1.78 g), and then one drop of water. After stirring at 60° C. overnight, ethyl acetate and water were added to the reaction mixture, which was extracted with ethyl acetate. The organic extracts were dried over sodium sulphate and concentrated under reduced pressure. The residue was purified by chromatography. This gave tert-butyl 4-{4-[5-(2-hydroxyphenyl)-4,5-dihydro-1,2-oxazol-3-yl]-1,3-thiazol-2-yl}piperidine-1-carboxylate (1.70 g)

Quelle

DOI: 10.6084/m9.figshare.5104873.v1Patent: US09006266B2uspto-grants-2015_04